SCHEMBL2383709

SCHEMBL2383709

Cc1ccc2[nH]c3c(cc(-c4ccc(Br)cc4)c(=O)n3C)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ HPGD P15428 6/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ NPC1 O15118 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ PDE3B Q13370 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ HSD17B10 Q99714 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ MDH2 P40926 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2382552 0.88 ALDH1A1 (0.41) KDM4EALDH1A1HPGDMEN1NPC1
SCHEMBL6281112 0.88 KDM4E (0.41) KDM4EALDH1A1HPGDMEN1NPC1
SCHEMBL2381110 0.88 MAPK1 (0.43) KDM4EALDH1A1HPGDMEN1NPC1
SCHEMBL3867849 0.87 KDM4E (0.50) KDM4EALDH1A1HPGDMEN1NPC1
SCHEMBL2385245 0.87 MAOB (0.41) KDM4EALDH1A1HPGDMEN1NPC1
SCHEMBL2383613 0.86 ALDH1A1 (0.41) KDM4EALDH1A1HPGDMEN1NPC1
SCHEMBL3444475 0.85 ACHE (0.46) KDM4EALDH1A1HPGDMEN1NPC1
SCHEMBL2383622 0.85 LMNA (0.43) ALDH1A1HPGDMEN1KMT2ALMNA
SCHEMBL2382846 0.84 HPGD (0.37) KDM4EALDH1A1HPGDMEN1NPC1
Hydrochloric Acid SCHEMBL3445384 0.84 ACHE (0.45) KDM4EALDH1A1HPGDMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012991-B2 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent; amidating a 2-aminoindole with an alpha-substituted-beta-hydroxy-alkyl acrylate SANOFI-AVENTIS (FR) 2011-09-06 — — US disclosed
US-20080214538-A1 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics SANOFI-AVENTIS (FR) 2008-09-04 — — US disclosed
US-7390818-B2 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics SANOFI-AVENTIS (FR) 2008-06-24 — — US disclosed
US-20050288318-A1 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics SANOFI-AVENTIS (FR) 2005-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288318-A1 Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics PNPO, PDXK, PLPBP KDM4E 2053/4885ALDH1A1 563/4885HPGD 72/4885
US-20080214538-A1 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics PNPO, PLPBP, DPYD KDM4E 2813/4885ALDH1A1 776/4885HPGD 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback